Circumvention of TKI resistance with HDAC inhibitors in lung cancer

被引：0
|
作者：
Yano, Seiji [1 ]
机构：
[1] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 9201192, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
JS1-5
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [1] HDAC Inhibitors Overcome New Generation EGFR-TKI-Resistance Caused by Homozygous BIM Polymorphism in EGFR Mutant Lung Cancer
    Yano, Seiji
    Tanimoto, Azusa
    Arai, Shoko
    Fukuda, Koji
    Ong, Sin T.
    Takeuchi, Shinji
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S296 - S297
  • [2] Circumvention of molecular targeted drug-resistance in lung cancer
    Yano, Seiji
    CANCER SCIENCE, 2023, 114 : 1558 - 1558
  • [3] New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer
    Zhang, Ying
    Yang, Shao-Hui
    Guo, Xiu-Li
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 96 : 659 - 666
  • [4] Amphiregulin confers in vivo crizotinib-resistance of EML4-ALK lung cancer and circumvention by EGFR inhibitors
    Taniguchi, Hirokazu
    Takeuchi, Shinji
    Fukuda, Koji
    Nakagawa, Takayuki
    Arai, Sachiko
    Nanjo, Shigeki
    Yamada, Tadaaki
    Yamaguchi, Hiroyuki
    Mukae, Hiroshi
    Yano, Seiji
    CANCER SCIENCE, 2018, 109 : 736 - 736
  • [5] Combination of HDAC and topoisomerase inhibitors in small cell lung cancer
    Gray, Jhanelle
    Cubitt, Christopher L.
    Zhang, Shumin
    Chiappori, Alberto
    CANCER BIOLOGY & THERAPY, 2012, 13 (08) : 614 - 622
  • [6] SLK Causes Resistance to EGFR-TKI in Lung Cancer
    Ashraf, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2371 - S2372
  • [7] HDAC inhibitors and ionizing radiation Combinatorial strategy to combat lung cancer
    Sarkar, Devanand
    CANCER BIOLOGY & THERAPY, 2009, 8 (09) : 832 - 834
  • [8] Metabolic targeting, HDAC inhibitors, and non small cell lung cancer?
    Gray, S. G.
    O'Byrne, K. J.
    Ahmad, S.
    LUNG CANCER, 2009, 63 : S1 - S1
  • [9] Determination of sensitivity to BET and HDAC inhibitors in lung cancer cell lines
    Verdura, Sara
    Torres-Diz, Manuel
    Sanchez-Cespedes, Montserrat
    CANCER RESEARCH, 2017, 77
  • [10] Circumvention of gefitinib resistance by repurposing flunarizine via histone deacetylase inhibition in lung cancer
    To, Kenneth K.
    Cho, William C.
    CANCER RESEARCH, 2023, 83 (07)
12345